← Back to Clinical Trials
Recruiting NCT06845969

NCT06845969 Physiotherapy Dry Needling Accuracy

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06845969
Status Recruiting
Phase —
Sponsor University of Alberta
Condition Dry Needling
Study Type INTERVENTIONAL
Enrollment 60 participants
Start Date 2025-04-10
Primary Completion 2027-03-31

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Education: dry needling theoryEducation: Cadaver anatomy review

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 60 participants in total. It began in 2025-04-10 with a primary completion date of 2027-03-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this clinical trial is to learn if the addition of cadaver review improves: * the accuracy of physiotherapists who practice dry needling. * the perceived safety of dry needling by physiotherapists. Researchers will compare the effects of an anatomy review using cadaver material to that of an educational intervention not related to anatomy to see if the anatomy review improves the needling accuracy and safety of physiotherapist who practice dry needling as compared to the control intervention of education not related to anatomy. Participants will: * Needle three muscles related to safety and/or accuracy using ultrasound imaging to gather accuracy and safety measurements. * Take an initial knowledge exam capturing their knowledge on needling safety. * Be randomized into a control group or intervention group. * The control group will receive an online educational session not related to anatomy. * The intervention group will receive a cadaver anatomy review class focused on high-risk area. * Re-take a knowledge exam after their course (either cadaver lab or on-line education) to capture any change. * Needle the same three muscles again using ultrasound to capture accuracy and safety measurements. If reviewing anatomy using cadaver materials improve physiotherapists needling accuracy and safety, then this educational intervention could be recommended to be added to dry needling course instruction.

Eligibility Criteria

Inclusion Criteria: * Physiotherapy volunteers: Physiotherapists who are in good standing with their regulatory College and licensed to practice dry needling. * Needling volunteers (those who will be needled) must be able to provide informed consent Exclusion Criteria: * Physiotherapy volunteers: Physiotherapists who are not in good standing with their regulatory College or not licensed to practice dry needling or have taken a cadaver review class post-graduation from their entry to practice physiotherapy program. * Needling volunteers (those who will be needled): Anyone who posses any contraindications to dry needling or not within normal BMI measurements

Contact & Investigator

Central Contact

Nadine R Crocker, MScPT

✉ nrrissli@ualberta.ca

📞 7806907442

Principal Investigator

Eric Parent, PhD

PRINCIPAL INVESTIGATOR

University of Alberta

Frequently Asked Questions

Who can join the NCT06845969 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Dry Needling. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06845969 currently recruiting?

Yes, NCT06845969 is actively recruiting participants. Contact the research team at nrrissli@ualberta.ca for enrollment information.

Where is the NCT06845969 trial being conducted?

This trial is being conducted at Edmonton, Canada.

Who is sponsoring the NCT06845969 clinical trial?

NCT06845969 is sponsored by University of Alberta. The principal investigator is Eric Parent, PhD at University of Alberta. The trial plans to enroll 60 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology